All Segments
How LSD transformed Neuroscience | Podcast Clips
5 segments available
Dennis McKenna is the founder of the McKenna Academy and has conducted research in ethnopharmacology for over 40 years. He is a founding board member of the Heffter Research Institute, and was a key investigator on the Hoasca Project, the first biomedical investigation of ayahuasca. Full Podcast: https://youtu.be/brOj7SINykM Important Links: - McKenna Academy: [https://mckenna.academy/] - ESPD 55 (Ethnopharmacologic Search for Psychoactive Drugs): [https://espd55.com/] - Twitter: [https://twitter.com/DennisMcKenna4] - ICEERS (International Center for Ethno-botanical Education, Research, and Service): [https://www.iceers.org/]
Segments Timeline
The Fear of Academic Persecution
Dennis McKenna discusses the fear of persecution that prevents many credentialed researchers in medicine and psychiatry from speaking out against government narratives regarding psychedelics. He highlights the pressures of funding, status, and tenure in academia, which can lead to a culture of silence among those who know the truth about the potential benefits of psychedelics.
"one of the questions that i wanted to get your opinion on is at the time that this was happening there were a number of researchers both here in the united states in canada and in europe who had were ..."
LSD: A Catalyst for Neuroscience
In this segment, McKenna explains how LSD served as a transformative tool in the birth of modern neuroscience. He describes how researchers in the 1950s used LSD to explore consciousness and its connection to psychosis, leading to significant insights into the molecular mechanisms of altered states of consciousness.
"reason i never tried to get tenure because i was willing to to play the game you know and i wanted to teach and i taught a lot about psychedelics and people i think my my supervisors at the time i was..."
Psychedelics and Consciousness Research
McKenna elaborates on the initial perceptions of LSD as a model for psychosis and how researchers began to recognize its potential for understanding consciousness. He discusses the shift in perspective as researchers reported mystical experiences and insights gained from LSD, challenging the stigma surrounding its use.
"increased that desire because they could see that they were tools you know if back in the 50s before these things became stigmatized and that banned the vilified i mean lsd was what there was you know..."
Clinical Applications of LSD
This segment covers the clinical applications of LSD, particularly in treating alcoholism, as demonstrated by Humphrey Osmond's work in Saskatchewan. McKenna emphasizes the promising results from these studies and the subsequent marginalization of this research due to the prohibition of psychedelics.
"with consciousness you know and they the idea originally in the 50s the idea was well the the lsd stage is like schizophrenia it's like it's it's like a model of psychosis you know so if if they in th..."
The Impact of Prohibition on Psychedelic Research
McKenna discusses the consequences of the prohibition of psychedelics, particularly how the data from promising research was disregarded. He explains the criteria that led to the classification of these substances as Schedule I drugs, which stifled further exploration into their medical uses and benefits.
"especially alcoholism and that kind of thing humphrey osmond's work in in saskatchewan with alcoholics which can begin in the 50s and continue through the 60s very promising work you know and like the..."